Pharmeuropa: Revision of Residual Solvents Chapter 2.4.24 Published for Comments
Recommendation

18/19 March 2026
Vienna, Austria
On 30 September 2025, the European Pharmacopoeia published in Pharmeuropa 37.4 a fully revised draft of Chapter 2.4.24 Identification and control of residual solvents for public consultation.
According to the briefing note, the revision is mainly editorial, aiming to improve clarity and usability. Key updates include:
- A clearer distinction between non-targeted and targeted analysis approaches.
- Introduction of a separate system suitability solution prepared from a subset of Class 2 solvents.
- Updated chromatograms for Class 2 residual solvents, now also covering cyclopentyl methyl ether and tert-butyl alcohol.
The updated chapter now follows this structure:
- Introduction
- Principle
- Equipment
- Procedure
- Preparation of solutions
- Identification and confirmation of solvents in the substance to be examined (steps 1 and 2)
- Quantitation of identified or specified residual solvents (step 3 – limit test)
The draft text is available on the Pharmeuropa website (login required). Comments can be submitted until 31 December 2025 via the Pharmeuropa platform.
Related GMP News
14.01.2026FDA Warning Letter: OOS Handling and HPLC Method Validation
14.01.2026Eurachem Publishes New Guide on the Fitness for Intended Use of Analytical Equipment and Systems
07.01.2026Revised Ph. Eur. Chapters 2.9.42 and 2.9.43 on Dissolution Testing
07.01.2026Korean MFDS Publishes Data Collection on Dissolution Test Methods
18.12.2025FDA Form 483: Excel-Based Data Falsification and Duplicate Log Books
18.12.2025Questions and Answers on System Suitability Tests (SST) - Part 1


